Literature DB >> 10744504

Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein.

C F Brito1, C T Fonseca, A M Goes, V Azevedo, A J Simpson, S C Oliveira.   

Abstract

The Schistosoma mansoni gene coding for a 14-kDa fatty acid-binding protein was amplified by PCR and subcloned into the prokaryotic expression vector pMAL-c2. Escherichia coli DH5alpha was transformed with the pMAL-Sm14 construct, and gene expression was induced hr isopropyl-beta-D-thiogalactopyranoside. The resulting recombinant (r) fusion protein was purified by affinity chromatography and confirmed by immunoblot analysis using antimaltose-binding protein or anti-Sm14 antibodies. Additionally, an antibody isotype profile was determined in sera of schistosomiasis patients to rSm14 or soluble adult worm antigen preparation. IgG1 and IgG3 subclass antibodies to rSm14 were predominant in sera of all patients studied whereas low levels of IgM, IgA or IgE were measured. Expression of a S. mansoni gene encoding a vaccine candidate is an important step to better study human immune responses to defined antigens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744504

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  8 in total

1.  Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.

Authors:  F C Cardoso; R N A Pacífico; R A Mortara; S C Oliveira
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Recent Advances in Schistosomiasis.

Authors:  G. Richard Olds; Srinivasan Dasarathy
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

3.  Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.

Authors:  Paula B Varaldo; Luciana C C Leite; Waldely O Dias; Eliane N Miyaji; Fabio I G Torres; Vera C Gebara; Geraldo R G Armôa; Adriano S Campos; Denise C S Matos; Nathalie Winter; Brigitte Gicquel; Mônica M Vilar; Johnjoe McFadden; Marilia S Almeida; Miriam Tendler; Douglas McIntosh
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Human T cell and antibody-mediated responses to the Mycobacterium tuberculosis recombinant 85A, 85B, and ESAT-6 antigens.

Authors:  Gilson C Macedo; Adriana Bozzi; Helena Rachel Weinreich; Andre Bafica; Henrique C Teixeira; Sergio C Oliveira
Journal:  Clin Dev Immunol       Date:  2010-12-29

Review 5.  Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant.

Authors:  Miriam Tendler; Marilia Almeida; Andrew Simpson
Journal:  Front Immunol       Date:  2015-05-12       Impact factor: 7.561

6.  Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection.

Authors:  Edward J Farnell; Nidhi Tyagi; Stephanie Ryan; Iain W Chalmers; Angela Pinot de Moira; Frances M Jones; Jakub Wawrzyniak; Colin M Fitzsimmons; Edridah M Tukahebwa; Nicholas Furnham; Rick M Maizels; David W Dunne
Journal:  Front Immunol       Date:  2015-02-03       Impact factor: 7.561

Review 7.  Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Authors:  Cristina Toscano Fonseca; Sergio Costa Oliveira; Clarice Carvalho Alves
Journal:  Front Immunol       Date:  2015-03-09       Impact factor: 7.561

8.  Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.

Authors:  Leonardo P Farias; Fernanda C Cardoso; Patricia A Miyasato; Bogar O Montoya; Cibele A Tararam; Henrique K Roffato; Toshie Kawano; Andrea Gazzinelli; Rodrigo Correa-Oliveira; Patricia S Coulson; R Alan Wilson; Sérgio C Oliveira; Luciana C C Leite
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.